Austrálie - angličtina - Department of Health (Therapeutic Goods Administration)

hospira australia pty ltd - pentamidine isetionate, quantity: 300 mg - injection, powder for - excipient ingredients: - 1. as an alternative first line treatment for pneumocystis carinii pneumonia/infection in aids patients. 2. as second line treatment for pneumocystis carinii pneumonia/infection in non-aids patients; 3. as second line treatment of leishmaniasis (visceral and cutaneous), except leishmania aethiopica where it may be used as first line therapy; 4. as second line treatment for trypanosomiasis (haemolymphete stage only) (except for the trypanosomiasis rhodesiense strain due to lack of efficacy).

Austrálie - angličtina - Department of Health (Therapeutic Goods Administration)

hospira australia pty ltd - pentamidine isetionate, quantity: 300 mg - injection - excipient ingredients: - how pentamidine, powder for injection solution is used: a) pneumonia due to the pneumocystis carinii, in weak, sick patients or the immunocompromised, such as for former patients with sida. these patients can have serious reactions to the treatment with cotrimoxazol. penamine isethionate is particularly valid in patients with a history of sulfonamides allergy. the pneumonia for p.carinii is the more common lethal infection opportunist in patients with syndrome of acquired immunodeficiency b) precocious phase of african sleeping sickness, due to trypanosoma gambiense c) treatment of leishmaniosis (kala-azar), visceral and cutaneous. all the previously cited indications can be treated by means of parenteral administration of the product. the pneumonia due to p.carinii can also be treated by means of oral inhalation aiming at the presence of these microorganisms in the alveolar space.

Velká Británie - angličtina - MHRA (Medicines & Healthcare Products Regulatory Agency)

sanofi - pentamidine isetionate - powder for solution for injection - 300mg

Belgie - angličtina - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

sanofi belgium sa-nv - pentamidini isethionas 300 mg - eq. pentamidine 172,4 mg - powder for solution for injection; powder for nebuliser solution - 300 mg - pentamidine isethionate 300 mg - pentamidine isethionate

Kanada - angličtina - Health Canada

aventis pharma inc - pentamidine isetionate - powder for solution - 300mg - pentamidine isetionate 300mg - miscellaneous antiprotozoals

Spojené státy - angličtina - NLM (National Library of Medicine)

fresenius kabi usa, llc - pentamidine isethionate (unii: v2p3k60da2) (pentamidine - unii:673lc5j4lq) - nebupent is indicated for the prevention of pneumocystis jiroveci pneumonia (pjp) in high-risk, hiv-infected patients defined by one or both of the following criteria: i. a history of one or more episodes of pjp ii. a peripheral cd4+ (t4 helper/inducer) lymphocyte count less than or equal to 200/mm3 . these indications are based on the results of an 18-month randomized, dose-response trial in high risk hiv-infected patients and on existing epidemiological data from natural history studies. the patient population of the controlled trial consisted of 408 patients, 237 of whom had a history of one or more episodes of pjp. the remaining patients without a history of pjp included 55 patients with kaposi’s sarcoma and 116 patients with other aids diagnoses, arc or asymptomatic hiv infection. patients were randomly assigned to receive nebupent via the respirgard® ii nebulizer at one of the following three doses: 30 mg every two weeks (n=135), 150 mg every two weeks (n=134) or 300 mg every four weeks (n=139). the

Malta - angličtina - Medicines Authority

central procurement & supplies unit ub002 industrial estate, san gwann sgn 3000, malta - pentamidine diisethionate - powder - pentamidine diisethionate 300 mg - antiprotozoals

Malta - angličtina - Medicines Authority

central procurement & supplies unit ub002 industrial estate, san gwann sgn 3000, malta - pentamidine diisethionate - lyophilisate for preparation of an injection/infusion solution or a solution for a nebuliser - pentamidine diisethionate 300 mg - antiprotozoals

Malta - angličtina - Medicines Authority

central procurement & supplies unit ub002 industrial estate, san gwann sgn 3000, malta - pentamidine diisethionate - powder for solution for injection - pentamidine diisethionate 300 mg - antiprotozoals

Jihoafrická republika - angličtina - South African Health Products Regulatory Authority (SAHPRA)

pfizer laboratories (pty) ltd - powder - see ingredients - each vial contains pentamidine diisetionate 300 mg